Updated list, with some new additions (BGF and CGE completed, USW removed due to reduced arb gap):
CASH ONLY
AAC - $4.90 offer, projected close end of 1st quarter.
AATT - $25.50 offer, financing not in place and no shareholder vote yet, anticipated January shareholder meeting.
ATPX - $14.50 offer, projected close by end of January.
CARL - around $2.45 offer, projected close by end of Febuary.
COOK - $5.25 offer, no other info.
DENT - $9.50 offer, projected 1st quarter close.
GIBG - $10.25 offer, DOJ requested additional info, tender currently expires January 5th (likely to be extended).
HERBA/HERBB - $17 offer, financing not in place and not enough tendered yet, extended to late January (and could be extended again).
KROG - $18 offer, projected February close.
LUCK - $12 offer, financing may or may not be in place and no shareholder vote yet, anticipated close 1st half 2000.
PLAY - $8.50 offer, PLAY shareholders have approved.
TFH - $6.03, expected shareholder meeting January, very small cap.
VIAS - $9 offer, DOJ antitrust challenge, extended to January 10th.
WDN - $23.25 offer, no shareholder vote yet, possible mid-February close.
CASH AND STOCK
BOSS - 1.25 shares MAK; $13.50 cash (up to 50%).
CTZ - $52 share cash and FNF stock, collar on FNF, anticipated close 1st Qtr 2000.
NVX - $7, $6.97 cash, depends on drug approval.
STRX - $10.50 minimum, could be up to 50% cash, .525 shares WAXS.
HRD - $79, shareholder meeting February 10th.
PALX - $9 cash and IFCO stock, not comfortable with proposed capital structure.
PBSF - $29, about 50/50 cash/stock with CYN.
STOCK ONLY
TVGIA - .6573 shares of GMST for each TVGIA.
UMG - Depends on T stock and UMG shareholder preferences, awaiting regulatory approval.
Other Potential Plays (i.e., in limbo or spinoff related): AVDO, PFG, SIMN, DZTK/PFSW, IDTC/NTOP.
KJ |
